NONS Shows Potential to Stop Glenmark Pharmaceuticals

NONS Shows Potential to Stop Glenmark Pharmaceuticals Glenmark Pharmaceuticals plans to test its upcoming nitric oxide nasal spray (NONS), which it has licensed from a Canadian biotech firm, as a preventive measure for COVID-19. The firm, which has tasted success with its oral antiviral drug Favipiravir, is now betting on …

Read more